SAT0393 EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY

Article info

Saturday, 15 June 2019

Psoriatic arthritis

SAT0393 EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY

Free

Proton Rahman Memorial University of Newfoundland, St. John’s, Canada PubMed articles Google scholar articles
Regan Arendse University of Saskatchewan, Saskatoon, Canada PubMed articles Google scholar articles
Isabelle Fortin Centre Rhumatologie de l’Est, Rimouski, Canada PubMed articles Google scholar articles
Andrew Chow University of Toronto, Toronto, Canada PubMed articles Google scholar articles
Majed Khraishi Nexus Clinical Research, St. John’s, Canada PubMed articles Google scholar articles
Suneil Kapur University of Ottawa, Ottawa, Canada PubMed articles Google scholar articles
Michel Zummer University of Montreal, Montreal, Canada PubMed articles Google scholar articles
Jon Chan Artus Health Centre, Vancouver, Canada PubMed articles Google scholar articles
Larissa Lisnevskaia Oshawa Clinic, Oshawa, Canada PubMed articles Google scholar articles
Raheem Kherani University of British Columbia, Richmond, Canada PubMed articles Google scholar articles
Emmanouil Rampakakis Janssen Inc, Toronto, Canada PubMed articles Google scholar articles
Odalis Asin Miilan Janssen Inc, Toronto, Canada PubMed articles Google scholar articles
Allen Lehman Janssen Inc, Toronto, Canada PubMed articles Google scholar articles
Meagan Rachich Janssen Inc., Toronto, Canada PubMed articles Google scholar articles
Francois Nantel Janssen Inc, Toronto, Canada PubMed articles Google scholar articles

Citation

Rahman P, Arendse R, Fortin I, et al

SAT0393 EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY

Annals of the Rheumatic Diseases 2019;78:1283.

Online issue publication

May 11, 2022